Previous Article | Next Article ![]()
Infection and Immunity, October 1999, p. 5041-5047, Vol. 67, No. 10
Department of Pathobiology, University of
Guelph, Guelph, Ontario N1G 2W1, Canada
Received 21 April 1999/Returned for modification 25 May
1999/Accepted 15 July 1999
The ability of Rhodococcus equi to induce pneumonia in
foals depends on the presence of an 85- to 90-kb plasmid. In this
study, we evaluated whether plasmid-encoded products mediate virulence by modulating the cytokine response of foals. Foals infected
intrabronchially with a virulence plasmid-containing strain of R. equi had similar gamma interferon (IFN- Rhodococcus equi, a
gram-positive facultative intracellular pathogen of macrophages, is one
of the most important causes of disease in foals between 1 and 5 months
of age. R. equi has also emerged as a significant
opportunistic pathogen in immunosuppressed people, especially those
infected with the human immunodeficiency virus (1, 6, 10).
Infection in either species is most commonly characterized by a
life-threatening pyogranulomatous pneumonia. R. equi is
widespread in the environment of horse breeding farms. Unlike most
environmental R. equi, isolates from pneumonic foals
typically contain an 85- to 90-kb plasmid encoding a highly immunogenic, lipid-modified virulence-associated protein (VapA) (30, 32-34). Plasmid-cured derivatives of virulent R. equi strains lose the ability to replicate and survive in
macrophages and fail to induce pneumonia in foals, confirming the
absolute necessity of the large plasmid for the virulence of R. equi (7, 36).
Study of the pathogenesis of R. equi infections has been
complicated by the fact that typical granulomatous lung lesions have not been reproduced by R. equi infection in any
immunocompetent species other than young horses. The normal murine lung
can progressively clear an inoculum of R. equi sufficient to
induce severe pneumonia in foals, suggesting that the results of
studies on the pathogenesis of this infection in mice may not
necessarily be extrapolated to foals. In mice, pulmonary clearance of
virulent (i.e., containing the VapA-encoding large plasmid) R. equi requires functional T lymphocytes (3, 37).
Although both CD4+ and CD8+ T cells contribute
to host defense against R. equi in mice, CD4+ T
lymphocytes play the major role and are absolutely required for
complete pulmonary clearance (13, 21, 24). Immunocompetent BALB/c mice experimentally infected with virulent R. equi
develop a Th1 cytokine response and progressively clear the infection (14). In contrast, mice in which a Th2 cytokine response was induced by administration of monoclonal antibodies (MAbs) against gamma
interferon (IFN- The Th1/Th2 paradigm defined for murine Th cell clones has provided a
useful framework for understanding immune response in infectious
diseases, but it remains to be established whether this paradigm can be
applied to the horse. The reasons for the peculiar susceptibility of
foals to R. equi infections are unknown. Study of the equine
immune response to infectious agents including R. equi has
been limited by the lack of species-specific reagents available for
measuring cytokines. However, the recent development of sensitive and
reproducible reverse transcription (RT)-PCR assays has made
quantitation of equine cytokine mRNA expression possible (9,
29).
Analogy to human immunodeficiency virus-related R. equi
pneumonia in humans suggests either that foals are immunocompromised in
some way or that infection with virulent R. equi alters
immune response in foals, or both. As the basis for the present study, we hypothesized that plasmid-encoded products mediate the virulence of
R. equi by modulating the cytokine response of infected
foals. To address this hypothesis, we compared interleukin-1 Bacteria.
The virulent R. equi strain
103+, originally isolated from a pneumonic foal, which
contains an 85-kb plasmid and produces VapA, and its avirulent
plasmid-cured VapA-negative derivative (strain 103 Infection of foals.
Twenty-two healthy mixed-breed pony
foals were used in this study, in conjunction with another study on the
role of the 85-kb plasmid and VapA in virulence of R. equi
(7). Adequate passive transfer of immunoglobulin was
confirmed in foals 12 to 24 h after birth, using an enzyme-linked
immunosorbent assay (ELISA) kit for semiquantitative measurement of
total immunoglobulin G (IgG) (Cite test; Idexx Laboratories, Westbrook,
Maine). Foals were reared with their mothers on pasture and were
monitored weekly for seroconversion to R. equi by using an
ELISA as previously described (23). At 18 to 23 days of age,
foals were moved with their dams to individual box stalls in an
isolation facility. Criteria for inclusion in the study were normality
in physical examination, lung sounds on auscultation, temperature,
radiographs of the lungs, and lack of seroconversion to R. equi by ELISA. Foals meeting these criteria were randomly assigned
to three experimental groups and infected 1 or 2 days after arrival in
the isolation facility. There were no differences in IgG antibody
titers against R. equi between groups at the time of infection.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Modulation of Cytokine Response of Pneumonic Foals
by Virulent Rhodococcus equi

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) and interleukin-12
(IL-12) p35 but significantly higher IL-1
, IL-10, IL-12 p40, and
tumor necrosis factor alpha (TNF-
) mRNA expression in lung tissue
compared to foals infected with the plasmid-cured derivative. IFN-
mRNA expression levels in CD4+ T lymphocytes isolated from
bronchial lymph nodes (BLN) were similar for the two groups of R. equi-infected foals on day 3 postinfection. However, on day 14, in association with pneumonia and marked multiplication of virulent
R. equi but with complete clearance of the plasmid-cured
derivative, IFN-
mRNA expression in BLN CD4+ T
lymphocytes was significantly (P < 0.001) higher in
foals infected with the plasmid-cured derivative. These results
suggests an immunomodulating role for R. equi virulence
plasmid-encoded products in downregulating IFN-
mRNA expression by
CD4+ T lymphocytes.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) fail to clear the infection and develop pulmonary
granulomas (14). More recently, adoptive transfer of
R. equi-specific Th1 or Th2 cell lines to R. equi-susceptible nude mice has clearly shown that a Th1 response
is sufficient to effect pulmonary clearance whereas a Th2 response is
detrimental (15).
(IL-1
), IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p35, IL-12 p40,
IFN-
, and tumor necrosis factor alpha (TNF-
) mRNA expression in
the lungs and bronchial lymph node (BLN) CD4+ T lymphocytes
of foals infected with a virulent plasmid-containing strain of R. equi to that of foals infected with a plasmid cured derivative of
the same strain.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) were
used (5). Aliquots of the two strains were stored at
70°C. Prior to use for infection of foals, the aliquots were grown
on Trypticase soy agar plates for 48 h at 37°C. Bacteria were
harvested with 4 ml of sterile phosphate-buffered saline (PBS) per
plate, the optical density of the resulting suspension was read at 540 nm, and the bacterial concentration was estimated from a standard
curve. The bacterial suspension was diluted with sterile PBS to a final
concentration of 5 × 107 bacteria/ml. The
concentration of the inoculum actually derived was determined
retrospectively by counting CFU.
; six foals that received only PBS were used as
controls. The day of infection was designated day 0. Half of the foals
in each group (103+, 103
, and controls) were
euthanized at 3 days postinfection, and half were euthanized at 14 days
postinfection by intravenous administration of a lethal dose of
pentobarbital sodium. Immediately after euthanasia, BLN were collected
aseptically and placed in sterile PBS for subsequent isolation of
CD4+ T lymphocytes. Lung samples (approximately 0.5 g)
were collected from a preselected site in the left cranioventral lung
lobe, rapidly frozen in liquid nitrogen, and stored at
70°C until
used for total RNA extraction.
Isolation of CD4+ T lymphocytes.
CD4+ T lymphocytes were isolated from the freshly collected
BLN by immunomagnetic separation using a previously characterized mouse
IgG anti-horse CD4 MAb (CVS4) (17). This antibody was generously donated by Paul Lunn, University of Wisconsin, and was used
as hybridoma supernatant. Briefly, BLN were cut into in
0.5-cm3 pieces, and the cells were separated in glass
tissue grinders. Mononuclear cells were separated by density gradient
centrifugation using endotoxin-free Ficoll-Paque (specific gravity,
1.077; Pharmacia Biotech, Baie d'Urfée, Québec, Canada)
and washed twice with cold PBS. The cells were counted and 4 × 107 cells were incubated at 4°C for 25 min with MAb CVS4.
After being washed twice in cold PBS, the cells were incubated at 4°C
for 25 min with a rat anti-mouse IgG fluorescein isothiocyanate
(FITC)-labeled MAb. The cells were then washed in PBS, resuspended in
magnetic cell sorter buffer (0.5% bovine serum albumin and 2 mM EDTA
in PBS), and incubated at 4°C for 15 min with anti-FITC microbeads (Miltenyi Biotec, Auburn, Calif.). CD4+ T lymphocytes were
obtained by positive selection magnetic cell sorting (VarioMACS;
Miltenyi Biotec) as specified by the manufacturer. CD4+
T-lymphocyte purity of all BLN preparations was determined before and
after immunomagnetic separation by flow cytometric analysis. CD4+ T lymphocytes were lysed in denaturing solution (4 M
guanidinium thiocyanate, 25 mM sodium citrate, 0.5% sodium
N-lauroylsarcosine, 0.1 M 2-mercaptoethanol) and kept frozen
at
70°C until used for total RNA extraction.
RNA isolation, DNase treatment of RNA samples, and cDNA synthesis. Total RNA was isolated by a modification of the single-step guanidinium thiocyanate procedure as previously described (4). RNA concentration was measured by optical density at 260 nm (GeneQuant II; Pharmacia Biotech). All RNA samples were treated with amplification-grade DNase I (Gibco BRL, Burlington, Ontario, Canada) to remove any traces of genomic DNA contamination. Briefly, 1 U of DNase I and 1 µl of 10× DNase I reaction buffer were mixed with 1.5 µg of total RNA to yield a 10-µl reaction mixture. The mixture was incubated for 10 min at room temperature and then inactivated by addition 1 µl of 25 mM EDTA and heating at 65°C for 10 min.
cDNA was synthesized with a first-strand cDNA synthesis kit (Clontech, Palo Alto, Calif.) as specified by the manufacturer. Briefly, 1.5 µg of total RNA was mixed with 1 µl of oligo(dT)18 primer (20 µM) and heated at 70°C for 2 min. After cooling to room temperature, the following reagents were added: 4 µl of 5× reaction buffer (250 mM Tris-HCl [pH 8.3], 375 mM KCl, 15 mM MgCl2), 1 µl of deoxynucleoside triphosphates (10 mM each), 0.5 µl of RNase inhibitor (40 U/µl), and 1 µl of Moloney murine leukemia virus reverse transcriptase (200 U/µl). The mixture was incubated at 42°C for 1 h, heated at 94°C for 5 min, diluted to a final volume of 100 µl, and stored at
70°C until
used for PCR analysis.
PCR analysis.
PCR primer pairs specific for equine
-actin, IL-1
, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p35, IL-12
p40, IFN-
, and TNF-
have been previously described
(9). cDNA prepared as described above (2 µl) was amplified
in a 50-µl PCR in the presence of 50 pmol of each primer,
deoxynucleoside triphosphates (0.2 mM each), 5 µl of 10× reaction
buffer (10 mM Tris-HCl [pH 8.3], 50 mM KCl), 1.5 mM
MgCl2, and 2 U of Taq DNA polymerase (AmpliTaq;
Perkin-Elmer, Branchburg, N.J.). PCR was performed with an initial
denaturation step at 94°C for 2 min and 40 cycles of amplification
followed by a 7-min extension at 72°C. Each cycle included
denaturation at 94°C for 45 s, annealing at 60°C for 45 s, and extension at 72°C for 2 min. Amplified PCR products were
visualized by electrophoresis of 10 µl of the reaction mixture on a
1.6% agarose gel followed by ethidium bromide staining. Samples
without cDNA were always included in the amplification reactions to
check for contamination. cDNA obtained from concanavalin A-stimulated
equine blood mononuclear cells was used as a positive control. RNA
samples were also subjected to PCR using the
-actin primers to
confirm the absence of genomic DNA contamination. The specificities of
the amplified bands were confirmed by visualizing a single band of
predicted size based on a molecular weight standard (100-bp DNA ladder;
Pharmacia Biotech).
Quantitation of mRNA by competitive PCR.
mRNA expression of
IL-1
, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p35, IL-12 p40, IFN-
,
TNF-
, and
-actin was determined quantitatively by competitive PCR
as previously described (9). Briefly, equal amounts of cDNA
were amplified in the presence of 2 µl of six fourfold serial
dilutions of heterologous DNA fragments (mimics). PCR was performed as
described above for 35 to 40 cycles. Following gel electrophoresis and
ethidium bromide staining, densitometric analysis of the bands
corresponding to the target and the mimic was performed with a gel
video system (Molecular Analyst; Bio-Rad, Hercules, Calif.). The
densitometric analysis results were used to plot a standard curve from
which the amount of target cDNA was determined. To account for
variation in the amount and quality of starting material, all results
were corrected to the mean
-actin value.
Statistical analysis.
The effects of bacterial strains and
time postinfection on the cytokine response of foals were analyzed by a
two-factorial analysis of variance (ANOVA) (27), and
adjusted means (least square [LS] means) were calculated by the
general linear model procedure of SAS (SAS System for Windows, version
6.10; SAS Institute, Cary, N.C.). In preliminary analysis, the effect
of sex, as assumed, was not significant and was therefore removed from
the final model. Data that were not normally distributed, as indicated
by the univariate procedure of SAS, were transformed to the natural
logarithm. For graphic presentation, LS means were converted back to
original units from loge transformed data. Consequently,
standard errors of means are not reported. Comparisons between
bacterial groups at each time point were made by performing a
t test on LS means (least significant difference test)
(27). In rare instances when normal distribution of the data
was not achieved even after loge transformation, the
results of the ANOVA were verified by the Kruskal-Wallis test. Results
were considered statistically significant if the value of P
was
0.05, and trends were reported if the P value was
0.10.
| |
RESULTS |
|---|
|
|
|---|
Experimentally induced R. equi bronchopneumonia.
The complete clinicopathologic description of the foals used in this
study has been reported elsewhere (7). Briefly, all foals
infected with R. equi 103+ developed macroscopic
lesions ranging from mild to moderate consolidation of the
cranioventral lung lobes on day 3 to severe consolidation involving 60 to 70% of the lung area on day 14. The BLN of
103+-infected foals were slightly enlarged on day 3 and
markedly enlarged on day 14. The lungs and BLN of
103
-infected foals and PBS controls were macroscopically
normal. Histologically, 103+-infected foals developed
lesions of suppurative to granulomatous bronchopneumonia, whereas the
lesions of 103
-infected foals were limited to mild
atelectasis and slight hypercellularity of the interalveolar septae. On
day 3 postinfection, the mean number of R. equi
(log10 per gram of lung ± standard deviation) in the
lungs of foals infected with strain 103+ (3.67 ± 1.35) was significantly higher than in those infected with strain
103
(1.43 ± 0.73). On day 14, the 103+
numbers had increased significantly (9.45 ± 1.0), whereas strain 103
could no longer be cultured. R. equi was
not cultured from the control foals (7).
Cytokine mRNA expression in the lungs of foals infected with
virulent and avirulent R. equi.
IL-1
, IL-2, IL-10, IL-12
p35, IL-12 p40, IFN-
, and TNF-
mRNA expression was detected in
the lungs of the foals used in this study. On day 3 postinfection,
IL-1
mRNA concentrations were significantly greater in
103+-infected foals than in those infected with
103
or the controls (Fig.
1). Foals infected with 103
had significantly greater IL-1
mRNA concentrations than the controls
on day 3, but these levels returned to baseline values on day 14 postinfection (Fig. 1). IL-10 mRNA expression was detected only in the
lungs of 103+-infected foals (Fig. 1). IL-12 p35 mRNA
expression was not statistically different among the three groups on
day 3, but there was a trend toward greater IL-12 p35 mRNA expression
in 103+-infected foals on day 14 (Fig. 1). IL-12 p40 mRNA
expression was significantly higher in 103+-infected foals
than in those infected with 103
or the controls on both
day 3 and day 14 (Fig. 1). IFN-
mRNA expression was significantly
greater in R. equi-infected foals than in the controls.
Although mean lung IFN-
mRNA concentrations were consistently
greater in 103+-infected foals than in those infected with
103
, this difference was not statistically significant on
day 3. There was, however, a trend toward higher IFN-
mRNA
expression for 103+-infected foals on day 14 (Fig. 1).
Levels of TNF-
mRNA expression were similar in the two groups of
R. equi infected foals on day 3, while low expression of
this cytokine was detected in only one control; on day 14, TNF-
mRNA
expression had not changed in 103+-infected foals, while
expression of this cytokine had returned to baseline values in the
foals infected with 103
(Fig. 1). Very low IL-2 mRNA
expression was detected qualitatively in the lungs of all R. equi-infected foals and four controls (data not shown), but mRNA
expression was too low for accurate quantitation by competitive PCR.
IL-4, IL-5, and IL-6 mRNA expression was not detected. Statistically
significant differences in cytokine mRNA expression in lung tissues
between the two groups of R. equi-infected foals are
summarized in Table 1.
|
|
Isolation of CD4+ T lymphocytes from BLN of foals infected with virulent and avirulent R. equi. Because differences in cytokine mRNA expression in lung tissue may have resulted from different proportions of some cell populations between groups, and because we were interested in investigating possible Th1/Th2 cytokine responses of foals infected with virulent and avirulent R. equi, CD4+ T lymphocytes were isolated from BLN by magnetic cell sorting. Percentage of CD4+ T cells as assessed by flow cytometry ranged from 88.5 to 99.1%, with a mean ± standard deviation of 95.1% ± 4.2%. There were no statistically significant differences in the percentage of CD4+ T lymphocytes between groups of foals.
Cytokine mRNA expression in CD4+ T lymphocytes isolated
from the BLN of foals infected with virulent and avirulent R. equi.
IL-12 p35 mRNA concentrations were significantly higher in
103+-infected foals than in those infected with
103
, but IL-12 p35 was not detected in the controls (Fig.
2). On day 3, IFN-
mRNA expression was
not significantly different between the two groups of R. equi-infected foals. However, on day 14 (when 103+-infected foals had severe pyogranulomatous
bronchopneumonia and very large numbers of R. equi in their
lungs, and 103
-infected foals were free of macroscopic
lung lesions and had completely cleared R. equi from their
lungs), mean IFN-
mRNA concentrations were significantly
(P < 0.001) greater in 103
-infected
foals. Despite a 600,000-fold increase in bacterial numbers between day
3 and day 14 in 103+-infected foals, the amount of IFN-
mRNA expression did not change in this group (Fig. 2). IL-2 and IL-10
mRNA expression was significantly higher in R. equi-infected
foals than in the controls, but there were no statistically significant
differences in mRNA expression of these cytokines between
103+- and 103
-infected foals (Fig. 2). IL-4
mRNA expression was not detected on day 3. On day 14, IL-4 mRNA
expression was detected from all four foals infected with
103+, from two of four foals infected with
103
, and from one of three controls, but mean IL-4 mRNA
expression was not statistically different between groups. IL-6 mRNA
concentrations were significantly higher in 103+-infected
foals than in the other two groups, but IL-6 mRNA expression in foals
infected with 103
was not significantly different from
that of the control group (Fig. 2). Statistically significant
differences in cytokine mRNA expression in BLN CD4+ T
lymphocytes between the two groups of R. equi infected foals are summarized in Table 1.
|
| |
DISCUSSION |
|---|
|
|
|---|
Both a virulent plasmid-containing strain of R. equi and its avirulent plasmid-cured derivative induced in vivo expression of mRNA for several inflammatory and regulatory cytokines in the natural host, the foal. This study demonstrated drastic differences in cytokine induction between virulent and avirulent R. equi, supporting the hypothesis that plasmid-encoded products play an immunomodulatory role by modifying cytokine response.
The virulent, plasmid-containing strain of R. equi induced
significantly more IL-1
, IL-10, and IL-12 p40 mRNA expression in
lung tissues than did the plasmid-cured derivative (Fig. 1). Levels of
TNF-
mRNA expression were similar in the two groups of R. equi-infected foals on day 3 postinfection. However, on day 14, when the foals infected with avirulent R. equi had
completely cleared the infection and were free of visible lung lesions,
their TNF-
mRNA expression had returned to baseline values (Fig. 1). These results demonstrate that prolonged induction of inflammatory cytokine in R. equi-infected foals requires establishment of
infection which, as previously shown, depends on the presence of the
85-kb plasmid (7, 36). As opposed to foals where the 85-kb
plasmid is absolutely required for virulence, opportunistic infections in immunosuppressed people do not always result from R. equi
strains containing the large plasmid and expressing VapA
(31). The present results in foals differ from those of a
recent study of mice in which intravenous inoculation with another
virulent plasmid-containing strain of R. equi resulted in
IFN-
and TNF-
production in the spleen, liver, and lungs, whereas
only minimal concentrations of these cytokines were detected in mice
infected with the plasmid-cured derivative (16). In the same
study, IL-4 and IL-10 were not detected in mice infected with either
strain of R. equi (16). These differences likely
reflect species differences but may also reflect the greater
sensitivity of RT-PCR as used here than of ELISA performed on the
murine tissue homogenates.
Differences in cytokine mRNA expression in lungs of R. equi
103+- and 103
-infected foals may have
resulted in part from different proportions of some cell populations.
Because we were interested in investigating the possible relevance and
existence of Th1/Th2 cytokine patterns in foals infected with virulent
and avirulent strains of R. equi, CD4+ T cells
were isolated from BLN by magnetic cell sorting. Preliminary attempts
to isolate CD4+ T cells via negative selection by depletion
of CD8+ T lymphocytes were unsuccessful, likely because of
the high proportion of CD4
CD8
T
lymphocytes in the lungs of young horses (2). Positive
immunomagnetic separation by using a MAb to equine CD4 resulted in a
mean percentage of CD4+ T lymphocytes of 95%. Although
positive immunomagnetic selection using a MAb to CD4 may, by itself,
induce cytokine production (26), this effect, if present,
was likely minimal in the present study, as assessed by the very low
induction of most cytokines in cells from control foals (Fig. 2).
Others have also shown that positive immunomagnetic separation of
CD4+ T lymphocytes results in preservation of various cell
functions, including cytokine generation (12, 18).
IL-6 and IL-12 p35 mRNA expression was significantly greater in
CD4+ T lymphocytes of foals infected with virulent
plasmid-containing R. equi (Fig. 2). Although statistically
significant, differences in IL-12 p35 mRNA expression between the two
groups of R. equi-infected foals are unlikely to have
biological significance because IL-12 p40 was not detected and IL-12 is
biologically active only when secreted as a heterodimer. In mice and
humans, a wide variety of cells (including T cells) have the ability to
produce IL-12 p35 (35). However, only macrophages,
neutrophils, and B lymphocytes can also produce the p40 subunit and
therefore secrete biologically active IL-12 (35). The
significantly higher IFN-
mRNA expression in
103
-infected foals than in those infected with
103+ on day 14 postinfection suggests a role for
plasmid-encoded products in downregulating IFN-
mRNA expression by
CD4+ T lymphocytes in association with progression of
infection. The downregulation of IFN-
mRNA expression observed on
day 14 in BLN CD4+ T lymphocytes was not, however,
reflected in lung tissues, where there was a trend toward higher
IFN-
mRNA in 103+-infected foals (Fig. 1). Virulence
plasmid-associated downregulation of IFN-
induction has also been
found in mice infected with Yersinia pestis, another
facultative intracellular pathogen with a large virulence plasmid
(20). In mice, IFN-
-producing CD4+ T
lymphocytes are essential for the clearance of virulent R. equi (15). The present results therefore support the
hypothesis that plasmid-associated downregulation of IFN-
mRNA
expression by CD4+ T lymphocytes in vivo in foals plays an
important role in the pathogenesis of R. equi-induced disease.
It is unclear whether the reduced IFN-
induction by CD4+
T cells associated with progression of infection with virulent R. equi was associated with an enhanced Th2-like response. Although mean BLN CD4+ T-cell IL-4 mRNA concentrations were more
than 30 times higher in 103+-infected foals than in those
infected with 103
on day 14, this difference was not
statistically significant, given the variability in IL-4 mRNA
expression and the small number of foals sampled. If the differences
between groups and variance observed in this study are adequate
estimates of the population, detection of significant differences among
103+- and 103
-infected foals in IL-4 mRNA
expression with an 80% probability at a P
0.05
level would have required a sample size of 16 foals per group.
Suppression of IFN-
induction has also been reported for
mycobacterial infections. Compared with healthy human tuberculin reactors, Mycobacterium tuberculosis-stimulated blood
mononuclear cells from clinical tuberculosis patients had diminished
mRNA expression and production of the Th1 cytokines IL-2 and IFN-
(38). Similarly, in cattle, progression of
Mycobacterium paratuberculosis infections to clinical stages
is associated with reduced IFN-
mRNA expression (28). As
is the case in the present study, these two reports failed to
demonstrate that the reduced IFN-
response was associated with
increased IL-4 response. Th2-independent mechanisms that could suppress
a Th1 response may include dysregulation of costimulatory molecules,
anergized T lymphocytes, or enhanced production of immunosuppressive
monokines such as transforming growth factor
(38). In
mice, IL-10 can downregulate the progression of Th cells toward the Th1
cytokine profile. Although IL-10 inhibited production of several Th1
and inflammatory cytokines, its effect was particularly marked on
IFN-
secretion (22). It may therefore be relevant that
IL-10 gene expression was detected in the lungs of all the foals
infected with virulent R. equi but not from any of the lungs
of foals infected with the plasmid-cured derivative. Whether or not
IL-10 production in lung tissue prevented the increase in IFN-
mRNA
by CD4+ T cells in 103+-infected foals remains
to be determined, but in those cells, there was no difference in IL-10
production between the two groups of R. equi-infected foals.
Optimal adherence of R. equi to macrophages requires
complement and is mediated almost exclusively by Mac-1, a complement receptor type 3 (11). Signaling through complement receptor type 3 has recently been shown to reduce macrophage production of
IL-12, thereby suppressing IFN-
production and Th1-driven cell-mediated immunity (19). In a recent study, however,
infection of mouse macrophages with R. equi 103+
or 103
failed to induce significant differences in
IL-1
, IL-6, IL-10, IL-12, and TNF-
mRNA expression or cytokine
production between the two groups over a 48-h period (8). In
the present study, levels of IL-12 p35 mRNA expression in lung tissues
were similar in both groups of R. equi-infected foals, and
IL-12 p40 mRNA expression was significantly higher in
103+-infected foals. Therefore, downregulation of IFN-
mRNA expression in CD4+ T lymphocytes by virulent R. equi does not appear to occur through suppression of IL-12
induction. Further studies are therefore needed to identify the
mechanisms underlying the depressed IFN-
response by
CD4+ T lymphocytes associated with the progression of the
disease caused by virulent plasmid-containing R. equi.
In conclusion, this study has shown that virulent R. equi
can modulate the cytokine response of the foal, its natural host. Downregulation of IFN-
mRNA expression in CD4+ T
lymphocytes by virulent R. equi may play an important role in the pathogenesis R. equi-induced disease in foals.
However, definitive understanding of the role of these cytokines in the pathogenesis of R. equi infections in foals awaits
production of the equine-specific anticytokine MAbs required to
modulate the cytokine response of horses.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Natural Sciences and Engineering Research Council of Canada, by the E. P. Taylor Equine Research Fund, and by the Ontario Ministry of Agriculture, Food and Rural Affairs. S. Giguère is the recipient of a fellowship from the Medical Research Council of Canada.
We thank William Matthes-Sears for assistance with statistical analysis.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Phone: (519) 824-4120, ext. 4717. Fax: (519) 767-0809. E-mail: jprescott{at}ovcnet.uoguelph.ca.
Present address: Department of Large Animal Clinical Sciences,
College of Veterinary Medicine, University of Florida, Gainesville, FL
32610-0136.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arlotti, M., G. Boboli, G. L. Moscatelli, G. Magnati, R. Maserati, V. Borghi, M. Andreoni, M. Libanore, L. Bonazzi, A. Piscina, and R. Ciammarughi. 1996. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand. J. Infect. Dis. 28:463-467[Medline]. |
| 2. | Balson, G. A., G. D. Smith, and J. A. Yager. 1997. Immunophenotypic analysis of foal bronchoalveolar lymphocytes. Vet. Microbiol. 56:237-246[Medline]. |
| 3. | Balson, G. A., J. A. Yager, and B. A. Croy. 1992. SCID/beige mice in the study of immunity to Rhodococcus equi, p. 49-53. In P. D. Rossdale, and J. F. Wade (ed.), Equine infectious diseases, 6th ed. R&W Publications, New Market, United Kingdom. |
| 4. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 5. | de la Pena-Moctezuma, A., and J. F. Prescott. 1995. Association with HeLa cells by Rhodococcus equi with and without the virulence plasmid. Vet. Microbiol. 46:383-392[Medline]. |
| 6. | Donisi, A., M. G. Suardi, S. Casari, M. Longo, G. P. Cadeo, and G. Carosi. 1996. Rhodococcus equi infection in HIV-infected patients. AIDS 10:359-362[Medline]. |
| 7. |
Giguère, S.,
M. K. Hondalus,
J. A. Yager,
P. Darrah,
D. Mosser, and J. F. Prescott.
1999.
Role of the 85-kb plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.
Infect. Immun.
67:3548-3557 |
| 8. |
Giguère, S., and J. F. Prescott.
1998.
Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.
Infect. Immun.
66:1848-1854 |
| 9. | Giguère, S., and J. F. Prescott. 1999. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet. Immunol. Immunopathol. 67:1-15[Medline]. |
| 10. | Harvey, R. L., and J. C. Sunstrum. 1991. Rhodococcus equi infections in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 13:139-145[Medline]. |
| 11. |
Hondalus, M. K.,
M. S. Diamond,
L. A. Rosenthal,
T. A. Springer, and D. M. Mosser.
1993.
The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells.
Infect. Immun.
61:2919-2929 |
| 12. | Jenne, L., J. Kilwinski, W. Scheffold, and P. Kern. 1997. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin. Exp. Immunol. 109:90-97[Medline]. |
| 13. |
Kanaly, S. T.,
S. A. Hines, and G. H. Palmer.
1993.
Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.
Infect. Immun.
61:4929-4932 |
| 14. | Kanaly, S. T., S. A. Hines, and G. H. Palmer. 1995. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 63:3037-3041[Abstract]. |
| 15. | Kanaly, S. T., S. A. Hines, and G. H. Palmer. 1996. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lungs. Infect. Immun. 64:1126-1132[Abstract]. |
| 16. |
Kasuga-Aoki, H.,
S. Takai,
Y. Sasaki,
S. Tsubaki,
H. Madarame, and A. Nakane.
1999.
Tumor necrosis factor and interferon- are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi.
Immunology
96:122-127[Medline].
|
| 17. | Lunn, D. P., M. A. Holmes, and P. H. Duffus. 1991. Three monoclonal antibodies identifying antigens on all equine T-lymphocytes, and two mutually exclusive T-lymphocyte subsets. Immunology 74:251-257[Medline]. |
| 18. | Manyonda, I. T., A. J. Soltys, and F. C. Hay. 1992. A critical evaluation of the magnetic cell sorter and its use in the positive and negative selection of CD45RO+ cells. J. Immunol. Methods 149:1-10[Medline]. |
| 19. |
Marth, T., and B. L. Kelsall.
1997.
Regulation of interleukin-12 by complement receptor 3 signaling.
J. Exp. Med.
185:1987-1995 |
| 20. |
Nakajima, R., and R. R. Brubaker.
1993.
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
Infect. Immun.
61:23-31 |
| 21. |
Nordman, P.,
E. Ronco, and C. Nauciel.
1992.
Role of T-lymphocyte subsets in Rhodococcus equi infection.
Infect. Immun.
60:2748-2752 |
| 22. | Powrie, F., D. Bean, and K. W. Moore. 1997. Interleukin 10, p. 143-152. In D. G. Remick, and J. S. Friedland (ed.), Cytokines in health and disease, 2nd ed. Marcel Dekker Inc., New York, N.Y. |
| 23. | Prescott, J. F., A. S. Fernandez, V. M. Nicholson, M. A. Patterson, J. A. Yager, L. Viel, and G. Perkins. 1996. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses. Equine Vet. J. 28:344-349[Medline]. |
| 24. | Ross, T. L., G. A. Balson, J. S. Miners, G. D. Smith, P. E. Shewen, J. F. Prescott, and J. A. Yager. 1997. Role of CD4+, CD8+ and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi. Can. J. Vet. Res. 60:186-192. |
| 25. | Sekizaki, T., S. Takai, Y. Egawa, T. Ikeda, H. Ito, and S. Tsubaki. 1995. Sequence of the Rhodococcus equi gene encoding the virulence-associated 15-17-kDa antigens. Gene 155:135-136[Medline]. |
| 26. | Stanciu, L. A., J. Shute, S. T. Holgate, and R. Djukanovic. 1996. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS). J. Immunol. Methods. 189:107-115[Medline]. |
| 27. | Steel, R. G. D., and J. H. Torrie. 1980. Principle and procedures of statistics. A biometrical approach, 2nd ed. McGraw-Hill, New York, N.Y. |
| 28. |
Sweeney, R. W.,
D. E. Jones,
P. Habecker, and P. Scott.
1998.
Interferon- and interleukin 4 gene expression in cows infected with Mycobacterium paratuberculosis.
Am. J. Vet. Res.
59:842-847[Medline].
|
| 29. | Swiderski, C. E., T. R. Klei, and D. W. Horohov. 1999. Quantitative measurement of equine cytokine mRNA expression by polymerase chain reaction using target-specific standard curves. J. Immunol. 222:155-169. |
| 30. | Takai, S., T. Anzai, Y. Sasaki, S. Tsubaki, and M. Kamada. 1993. Virulence of Rhodococcus equi isolated from lesions of infected foals. Bull. Equine Res. Inst. 30:9-14. |
| 31. | Takai, S., Y. Imai, N. Fukunaga, Y. Uchida, K. Kamisawa, Y. Sasaki, S. Tsubaki, and T. Sekizaki. 1995. Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with AIDS. J. Infect. Dis. 172:1306-1311[Medline]. |
| 32. |
Takai, S.,
T. Sekizaki,
T. Ozawa,
T. Sugawara,
Y. Watanabe, and S. Tsubaki.
1991.
Association between large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi.
Infect. Immun.
59:4056-4060 |
| 33. |
Takai, S.,
Y. Watanabe,
T. Ikeda,
T. Ozawa,
S. Matsukura,
Y. Tamada,
S. Tsubaki, and T. Sekizaki.
1993.
Virulence-associated plasmids in Rhodococcus equi.
J. Clin. Microbiol.
31:1726-1729 |
| 34. | Tan, C., J. F. Prescott, M. C. Patterson, and V. M. Nicholson. 1995. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can. J. Vet. Res. 59:51-59[Medline]. |
| 35. | Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin-12. J. Leukoc. Biol. 59:505-511[Abstract]. |
| 36. | Wada, R., M. Kamada, T. Anzai, A. Nakanishi, T. Kanemaru, S. Takai, and S. Tsubaki. 1997. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet. Microbiol. 56:301-312[Medline]. |
| 37. | Yager, J. A., C. A. Prescott, D. P. Kramar, H. Honnah, G. A. Balson, and B. A. Croy. 1991. The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Vet. Microbiol. 28:363-376[Medline]. |
| 38. | Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»